Journal of Microbiology, Immunology, and Infection This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Corrigendum to Evolution of estimated glomerular filtration rate in HIV/HCV-coinfected patients who received direct-acting antivirals: A multicenter retrospective study [J Microbiol Immunol Infect 56 (2023) 718-728]
J Microbiol Immunol Infect. 2023 Oct 12:S1684-1182(23)00193-7. doi: 10.1016/j.jmii.2023.10.002. Online ahead of print.NO ABSTRACTPMID:37838594 | DOI:10.1016/j.jmii.2023.10.002 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 14, 2023 Category: Microbiology Authors: Ching-Yen Tsai Guan-Jhou Chen Chin-Shiang Tsai Bo-Huang Liou Chia-Jui Yang Hung-Chin Tsai Chi-Ying Lin Sung-Hsi Huang Kuan-Yin Lin Ning-Chi Wang Tun-Chieh Chen Chen-Hsiang Lee Chien-Ching Hung Taiwan HIV Study Group Source Type: research

Assessing the cardiovascular events and clinical outcomes of COVID-19 on patients with primary aldosteronism
CONCLUSIONS: This study provides a comprehensive analysis of the cardiovascular impact of the COVID-19 pandemic on individuals with PA. The findings underscore the increased risk of mortality, critical care, MACE, and MAKE among patients with PA and COVID-19. The study highlights the need for continued optimization of strategies for follow-up care for patients with PA after SARS-CoV-2 infections.PMID:37827953 | DOI:10.1016/j.jmii.2023.09.005 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 12, 2023 Category: Microbiology Authors: Vin-Cent Wu Jui-Yi Chen Yen-Hung Lin Cheng-Yi Wang Chih-Cheng Lai Source Type: research

Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab
We present a retrospective study on the treatment outcomes of severely immunocompromised patients with persistent COVID-19. The study analyzed data from 14 patients who received a combination of tixegavimab/cilgavimab and antiviral medications. Response was evaluated based on symptom improvement, PCR cycle-threshold values, and C-reactive protein levels. Eleven patients achieved complete clinical and virological resolution, while three showed partial responses. The study suggests a potential association between non-response and tixegavimab/cilgavimab neutralization. The findings underscore the need for tailored treatment a...
Source: Journal of Microbiology, Immunology, and Infection - October 7, 2023 Category: Microbiology Authors: Tal Brosh-Nissimov Nir Ma'aravi Daniel Leshin-Carmel Yonatan Edel Sharon Ben Barouch Yafit Segman Amos Cahan Erez Barenboim Source Type: research

Angiotensin-(1-7) attenuates SARS-CoV2 spike protein-induced interleukin-6 and interleukin-8 production in alveolar epithelial cells through activation of Mas receptor
This study aims to investigate whether SARS-CoV-2 SP can induce inflammation through ACE2 in the alveolar epithelial cells which can be modulated through angiotensin-(1-7)/Mas receptor axis.METHODS: HPAEpiC were treated with SARS-CoV-2 SP in the presence or absence of ACE2 antagonist-dalbavancin and Mas receptor agonist-angiotensin-(1-7). Proinflammatory cytokine production (IL-6 and IL-8) were measured at mRNA and protein levels. MAP kinase phosphorylation and transcription factor activation was determined by Western Blot. Mas receptor was blocked by either antagonist (A779) or knockdown (specific SiRNA). Experiments were...
Source: Journal of Microbiology, Immunology, and Infection - October 6, 2023 Category: Microbiology Authors: Yi-Luen Shen Yi-An Hsieh Po-Wei Hu Po-Chun Lo Yi-Han Hsiao Hsin-Kuo Ko Fang-Chi Lin Chien-Wen Huang Kang-Cheng Su Diahn-Warng Perng Source Type: research

Incremental yield of serial sputum examinations in the diagnosis of pulmonary tuberculosis in Taiwan: Findings of a pragmatic trial
CONCLUSIONS: The incremental yield of the third sputum smear was negligible. It may be reasonable to perform an NAAT, smear and culture on the first specimen and culture alone on the second. The utility of the third serial culture for the detection of additional TB case is debatable.PMID:37802687 | DOI:10.1016/j.jmii.2023.09.006 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 6, 2023 Category: Microbiology Authors: Chen-Yuan Chiang Chih-Bin Lin Shun-Tien Chien Cheng-Hui Wang Yi-Wen Huang Wei-Chang Huang Ming-Chih Yu Jen-Jyh Lee Hans L Rieder Source Type: research

Survival benefit of a third dose of the COVID-19 vaccine among hemodialysis patients: A prospective cohort study
CONCLUSION: A third dose of the COVID-19 vaccine was associated with a decreased risk of all-cause mortality among HD patients during the Omicron-dominant period. A higher post-vaccination anti-S protein RBD antibody level was also associated with a lower risk of mortality.PMID:37770324 | DOI:10.1016/j.jmii.2023.09.002 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - September 28, 2023 Category: Microbiology Authors: Tz-Heng Chen Yang Ho Hsin-Ling Tai Yuan-Chia Chu Yao-Ping Lin Chih-Yu Yang Wei-Cheng Tseng Shuo-Ming Ou Ming-Tsun Tsai Jinn-Yang Chen Tsai-Hung Wu Kuo-Hua Lee Fan-Yu Chen Szu-Yuan Li Chih-Ching Lin Der-Cherng Tarng Source Type: research